The Montel Williams MS Foundation today announced a grant to Providence-based Epivax, Inc., the first biotech-related company to be awarded a grant from the foundation.

Epivax is a privately held company run by Anne Searls DeGroot that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry. The size of the grant was not disclosed.

In all, the foundation made grants totaling $325,000 to institutions studying new treatments for MS, methods for restoring MS-depleted myelin throughout the nervous system, and methods for early detection, which has been shown to slow or halt the progression of the disease.